Macrophage Pharma

About:

Macrophage Pharma is a immune-oncology company

Website: https://www.macrophagetx.com/

Top Investors: Novo Holdings, M Ventures, Aglaia BioMedical Ventures, Sixth Element Capital

Description:

Macrophage Pharma is an immuno-oncology company focused on the discovery and development of novel therapies designed to enhance anti-tumour immune responses. The company’s technology platform is designed to deliver small molecule drugs to tumour associated macrophages in a highly selective manner to activate the body’s natural immune system to fight cancer.

Total Funding Amount:

9M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Dublin, Ohio, United States

Founded Date:

2014-01-01

Contact Email:

enquiries(AT)macrophagepharma.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2017-01-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai